nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Agony of choice—selecting chronic lymphocytic leukemia treatment in 2022
|
Bohn, Jan-Paul |
|
|
15 |
2 |
p. 121-124 |
artikel |
2 |
Antibody–drug conjugates—the magic bullet?
|
Aretin, Marie-Bernadette |
|
|
15 |
2 |
p. 125-128 |
artikel |
3 |
Breast Cancer—Essential news of current guidelines
|
Strasser-Weippl, Kathrin |
|
|
15 |
2 |
p. 117-120 |
artikel |
4 |
Cardiopulmonary sequelae of COVID-19
|
|
|
|
15 |
2 |
p. 161-164 |
artikel |
5 |
COVID-19 crisis and cancer
|
Bartsch, Rupert |
|
|
15 |
2 |
p. 98-99 |
artikel |
6 |
COVID-19: New disease mechanism is simultaneously a therapeutic target
|
Schmitt, Clemens A. |
|
|
15 |
2 |
p. 100-101 |
artikel |
7 |
Current state of clinical development of TROP2-directed antibody–drug conjugates for triple-negative breast cancer
|
Marhold, Maximilian |
|
|
15 |
2 |
p. 129-132 |
artikel |
8 |
ESMO 2021
|
Bartsch, Rupert |
|
|
15 |
2 |
p. 95-96 |
artikel |
9 |
ESMO 2021—highlights in colorectal cancer
|
Weiss, Lukas |
|
|
15 |
2 |
p. 114-116 |
artikel |
10 |
ESMO 2021—my top three abstracts in breast cancer
|
Suppan, Christoph |
|
|
15 |
2 |
p. 111-113 |
artikel |
11 |
Hemophagocytic lymphohistocytosis in a COVID-19 patient in the acute phase: case report
|
Salamoon, Maher |
|
|
15 |
2 |
p. 149-152 |
artikel |
12 |
Highlights ESMO 2021—lung cancer
|
Rauter, Markus |
|
|
15 |
2 |
p. 107-110 |
artikel |
13 |
High mortality in patients with active malignancy and severe COVID-19
|
Udovica, Simon |
|
|
15 |
2 |
p. 153-160 |
artikel |
14 |
Immunotherapy pitfall: sarcoid-like reaction mimicking disease progression in advanced melanoma treated with nivolumab
|
Mutschlechner, Beatrix |
|
|
15 |
2 |
p. 169-172 |
artikel |
15 |
Neurotoxicity as a rare side effect of immune checkpoint inhibitors. A case report and review of the literature
|
Udovica, Simon |
|
|
15 |
2 |
p. 165-168 |
artikel |
16 |
New targeted therapies in kidney cancer
|
Mayrhofer, Karl |
|
|
15 |
2 |
p. 133-136 |
artikel |
17 |
New targeted therapies/small molecules in oncology and hematology
|
Berghoff, Anna Sophie |
|
|
15 |
2 |
p. 97 |
artikel |
18 |
Renal cell carcinoma—presentation highlights from the ESMO Congress 2021
|
Hutterer, Georg C. |
|
|
15 |
2 |
p. 102-106 |
artikel |
19 |
Systemic capillary leak syndrome following granulocyte colony-stimulating factor therapy in a T-lymphoblastic leukemia/lymphoma patient: a case report
|
Sharie, Ahmed H. Al |
|
|
15 |
2 |
p. 143-148 |
artikel |
20 |
Tracking mutation and drug-driven alterations of oncokinase conformations
|
Feichtner, Andreas |
|
|
15 |
2 |
p. 137-142 |
artikel |